PAVmed (PAVM) Non-Current Debt (2017 - 2020)
PAVmed's (PAVM) quarterly Non-Current Debt came in at $100000.0 in Q3 2020, down 99.38% quarter-over-quarter from $16.2 million in Q2 2020.
PAVmed (PAVM) Non-Current Debt (2017 - 2020) Analysis & Trends
PAVmed's Non-Current Debt history runs 4 years deep, the most recent figure standing at $100000.0 for Q3 2020.
- On a quarterly basis, Non-Current Debt changed N/A year-over-year to $100000.0 in Q3 2020; TTM through Sep 2020 was $100000.0, a N/A change from a year earlier, with the FY2019 full-year figure at $8.1 million, changed N/A from the prior year.
- Non-Current Debt fell to $100000.0 in Q3 2020 per PAVM's latest filing, from $16.2 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $16.2 million in Q2 2020 and bottomed at $20663.0 in Q1 2020.
- The 4-year median for Non-Current Debt is $1.9 million (2017), against an average of $4.3 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 16.20 Mn |
| Mar 31, 2020 | 20,663.00 |
| Dec 31, 2019 | 8.14 Mn |
| Mar 31, 2018 | 2.25 Mn |
| Dec 31, 2017 | 1.94 Mn |
| Sep 30, 2017 | 1.58 Mn |